Mexico Health Review - Mexico Health Review 2017Add to Favorites

Mexico Health Review - Mexico Health Review 2017Add to Favorites

Magzter GOLDで読み攟題を利甚する

1 回の賌読で Mexico Health Review ず 9,000 およびその他の雑誌や新聞を読むこずができたす  カタログを芋る

1 ヶ月 $9.99

1 幎$99.99 $49.99

$4/ヶ月

保存 50%
Hurry, Offer Ends in 12 Days
(OR)

のみ賌読する Mexico Health Review

Subscription plans are currently unavailable for this magazine. If you are a Magzter GOLD user, you can read all the back issues with your subscription. If you are not a Magzter GOLD user, you can purchase the back issues and read them.

ギフト Mexico Health Review

この問題で

As 2017 turned the corner into a new year, macroeconomic uncertainty kept the world – and the global business community – on tenterhooks. The Mexican health industry cast a wary eye on events north of the border that were impacting the local exchange rate while also focusing treatment efforts on obesity and diabetes, which continued to top the country’s major health concerns. Considered as epidemics by the government, steps are being taken to eradicate these diseases in the country, especially through prevention. However, universal access to health, a key to promoting prevention in an increasingly aging population that is not accustomed to continuous medical checkups, remains an illusive ideal in the face of a fractured Mexican health system and the large number of people who continue to work informally, which complicates their access to a system marked by budget cuts. In this context, collaboration between the public and private sectors is vital for improving quality of life.

Mexico Health Review Magazine Description:

出版瀟: Mexico Business Publishing

カテゎリヌ: Business

蚀語: English

発行頻床: Yearly

Mexico is carving out a place on the global health stage with an increasing number of international companies choosing to set up Latin American headquarters in the country and with its CROs fighting for a bigger slice of the clinical research pie. The year 2016 was one of change in the Mexican public health sector, highlighted by new leadership and new policies promoting cost-effectiveness and efficiency. Mexico has continued to attract an increasing number of clinical trials and new companies, bringing fresh ideas and scientific innovation. An oncoming wave of patent expirations has further prompted medicinal innovation, with Big Pharma companies racing to discover the next big treatment while others prepare to release life-saving generics and biosimilars. But the country’s most common problems remain: obesity, diabetes and cancer are the top concerns for healthcare providers and the biggest drain on healthcare budgets, with the public and private sectors increasingly emphasizing the importance of prevention. The health industry advances at breakneck speed. Mexico Health Review offers insight into the changes to the public system over the year, the mind-blowing innovations under development and the growth opportunities the industry presents.

  • cancel anytimeい぀でもキャンセルOK [ 契玄䞍芁 ]
  • digital onlyデゞタルのみ